Committee
Prof. Itamar Raz, Israel
Itamar Raz
Itamar Raz MD is a professor of internal medicine, and the head of the Israeli council of diabetes.
- In the last 15 years, together with prof. Ning Guang and Prof. Stefano Del Prato he organized and led the yearly – Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) meetings in different part of the world, that was published in five diabetes care proceedings of the ADA.
- Prof Raz is a leader of the Diabetes Experts Forum, a group of worldwide top experts in diabetes.
- He has been co-principal investigator of large studies including DECLARE, SAVORE, IDNT, HEART2D and others.
- He is a co-editor in DMRR, DRCP, Cell and Drugs.
- He has published over 450 papers.
- In Israel, he is the president of two societies to improve and prevent obesity in young children and their families and to improve diabetes research and care for diabetic patients.
Prof. Guang Ning, China
Guang Ning
Guang Ning, MD, PhD
Head of Shanghai Clinical Center for Endochrine and Metabolic Disease, Director and Professor of Department of Endocrine and Metabolism in Ruijin Hospital, Director of Shanghai Institute for Endocrinology and Metabolism, Vice President of Ruijin Hospital affiliated Shanghai JiaoTong University School of Medicine
Guang Ning, the head of Shanghai Clinical Center for Endocrine and Metabolic Diseases, the director and professor of department of Endocrine and Metabolism in Ruijin Hospital, the director of Shanghai Institute for Endocrinology and Metabolism, the vice president of Ruijin Hospital affiliated Shanghai JiaoTong University School of Medicine. Dr Ning received his MD and PhD from Shanghai Second Medical University. He had been trained as Postdoctoral Fellow for 2 years in Baylor Medical College, USA. Dr. Ning has been focusing on the study of endocrine and metabolic diseases, such as type 2 diabetes and metabolic syndrome, pituitary and adrenal disorders, hereditary endocrine and metabolic diseases caused by single gene mutation, as well as the research on pathogenesis of endocrine related cancers. Dr. Ning has received more than 20 grants and published more than 300 scientific papers in peer-reviewed journals. Dr Ning is the Co-Editor-in-Chief of Journal of Diabetes. He also is the associate-editors for four medical science journals, including the Chinese Journal of Endocrinology and Metabolism, the Chinese Journal of Practical Internal Medicine, Shanghai Medical Journal and the Journal of Shanghai Jiaotong University (Medical Science), and also on the editorial boards of several journals. He is the vice-chairman of the Chinese Endocrine Society.
Prof. Stefano Del Prato, Italy
Stefano Del Prato
Stefano Del Prato is Professor of Endocrinology and Metabolism at the School of Medicine, University of Pisa and Chief of the Section of Diabetes of the Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. He graduated MD cum laude from the University of Padova and undertook post-graduate specialisation in both Endocrinology and Internal Medicine.
Professor Del Prato’s research interests have always been concerned with diabetes and, in particular, the physiopathology and therapy of type 2 diabetes and insulin resistance syndrome.
He is a member of many societies and associations, including the European Association for the Study of Diabetes (EASD), the American Diabetes Association, and the International Diabetes Federation. He acts as referee for all major journals and has served on the Editorial Boards for the Journal of Clinical Endocrinology and Metabolism, Diabetes Care, and the Journal of Diabetes and Its Complications, Journal of Endocrinological Investigation, and Diabetes & Vascular Disease Research.
Professor Del Prato has published over 500 articles in national and international journals and has been awarded several honours, including the Prize of the Italian Society of Diabetology for outstanding scientific activity. Having served as Vice-President of the EASD from 2011-14, he became President in 2020. He also served as President of Italian Society of Diabetology (2012-14) and as Chairman of the European Foundation for the Study of Diabetes (2015-18).
Duality of Interest: Professor Del Prato has received research support/grants from AstraZeneca and Boehringer Ingelheim and speaker’s fees/honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Novartis Pharmaceutical Company, Novo Nordisk, Sanofi and Takeda Pharmaceuticals. He has also received payments for membership of boards/advisory panels from Abbott, Amarin, Applied Therapeutics, AstraZeneca, Bayer, Eli Lilly & Co, GlaxoSmithKline, Hengrui Pharmaceuticals, Novartis Pharmaceutical Co, Novo Nordisk and Sanofi and consultancy payments from Menarini.